Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein-Protein Interaction with MiD49

被引：2
|
作者：
Furuya, Takeru [1 ,2 ]
Lin, Jean [1 ,3 ]
Afanaseva, Arina [1 ,4 ]
Molz, Lisa [1 ,5 ]
Lagu, Bharat [1 ]
Ma, Bin [1 ,6 ]
机构：
[1] Mitobridge Inc, Cambridge, MA 02138 USA
[2] Xontogeny, Boston, MA 02116 USA
[3] Mitobridge, Astellas, Cambridge, MA 02138 USA
[4] Astellas, Adv Informat & Analyt, Tsukuba, Ibaraki 3058585, Japan
[5] AvilarTherapeutics, Waltham, MA 02451 USA
[6] ArtBio Inc, Cambridge, MA 02142 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2023年 / 14卷 / 08期
关键词：
DRP1; MiD49; Protein-proteininteraction; Allosteric; inhibitor; Mitochondria; MITOCHONDRIAL DIVISION DYNAMIN; SMALL-MOLECULE INHIBITORS; FISSION; FUSION;
D O I：
10.1021/acsmedchemlett.3c00223
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Mitochondrialdysfunction has been attributed to many disease indications, includingmetabolic, cardiovascular, neoplastic, and neurodegenerative diseases.Dynamin related protein 1 (DRP1) is crucial in regulating mitochondrialfission and maintaining mitochondrial homeostasis. MiD49 is a dynamicperipheral protein receptor on the surface of the mitochondrial membranethat recruits DRP1 protein to induce mitochondrial binary fission.By targeting the protein-protein interaction of DRP1/MiD49,we have discovered a novel and potent allosteric DRP1 inhibitor thatinhibits mitochondria fragmentation in vitro. X-raycocrystal structure revealed that it locked the closed DRP1 conformationby induced dimerization.
引用
收藏
页码：1095 / 1099
页数：5
相关论文
共 50 条
  • [21] Discovery of Protein-Protein Interaction Inhibitors by Integrating Protein Engineering and Chemical Screening Platforms
    Maculins, Timurs
    Garcia-Pardo, Javier
    Skenderovic, Anamarija
    Gebel, Jakob
    Putyrski, Mateusz
    Vorobyov, Andrew
    Busse, Philipp
    Varga, Gabor
    Kuzikov, Maria
    Zaliani, Andrea
    Rahighi, Simin
    Schaeffer, Veronique
    Parnham, Michael J.
    Sidhu, Sachdev S.
    Ernst, Andreas
    Doetsch, Volker
    Akutsu, Masato
    Dikic, Ivan
    CELL CHEMICAL BIOLOGY, 2020, 27 (11): : 1441 - +
  • [22] Discovery of YAP-TEAD protein-protein interaction (PPI) inhibitors for cancer therapy
    Soude, Anne
    Barth, Martine
    Bocart, Stephanie
    Thoreau, Frederic
    Masson, Philippe
    Braccini, Isabelle
    Montalbetti, Christian
    Brogue, Pierre
    Fromond, Claudia
    CANCER RESEARCH, 2016, 76
  • [23] Discovery and Validation of RGS2-FBXO44 Protein-Protein Interaction Inhibitors
    Aryal, Sadikshya
    McNabb, Harrison J.
    Sjogren, Benita
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [24] Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity
    Chen, Weilin
    Chen, Xin
    Li, Dongdong
    Wang, Xianghan
    Long, Guanlu
    Jiang, Zhengyu
    You, Qidong
    Guo, Xiaoke
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [25] Allosteric regulation of the tyrosine phosphatase PTP1B by a protein-protein interaction
    Chartier, Cassandra A.
    Woods, Virgil A.
    Xu, Yunyao
    van Vlimmeren, Anne E.
    Johns, Andrew C.
    Jovanovic, Marko
    Mcdermott, Ann E.
    Keedy, Daniel A.
    Shah, Neel H.
    PROTEIN SCIENCE, 2025, 34 (01)
  • [26] Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction
    Gonzalez, Ana Z.
    Eksterowicz, John
    Bartberger, Michael D.
    Beck, Hilary P.
    Canon, Jude
    Chen, Ada
    Chow, David
    Duquette, Jason
    Fox, Brian M.
    Fu, Jiasheng
    Huang, Xin
    Houze, Jonathan B.
    Jin, Lixia
    Li, Yihong
    Li, Zhihong
    Ling, Yun
    Lo, Mei-Chu
    Long, Alexander M.
    McGee, Lawrence R.
    McIntosh, Joel
    McMinn, Dustin L.
    Oliner, Jonathan D.
    Osgood, Tao
    Rew, Yosup
    Saiki, Anne Y.
    Shaffer, Paul
    Wortman, Sarah
    Yakowec, Peter
    Yan, Xuelei
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Olson, Steven H.
    Medina, Julio C.
    Sun, Daqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2472 - 2488
  • [27] Macrocyclic inhibitors of the Sonic Hedgehog/patched 1 protein-protein interaction
    Owens, Andrew
    Fasan, Rudi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [28] From fragments to in vivo activity using X-ray crystallography: the discovery of potent inhibitors of the KEAP1-NRF2 protein-protein interaction
    Davies, Tom
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : E23 - E23
  • [29] Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors
    Otake, Kazuki
    Hara, Yoshinori
    Ubukata, Minoru
    Inoue, Masafumi
    Nagahashi, Noboru
    Motoda, Dai
    Ogawa, Naoki
    Hantani, Yoshiji
    Hantani, Rie
    Adachi, Tsuyoshi
    Nomura, Akihiro
    Yamaguchi, Keishi
    Maekawa, Mariko
    Mamada, Hideaki
    Motomura, Takahisa
    Sato, Motohide
    Harada, Kazuhito
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 3741 - 3763
  • [30] Pharmacophore Modelling as a Virtual Screening Tool for the Discovery of Small Molecule Protein-protein Interaction Inhibitors
    Voet, Arnout
    Zhang, Kam Y. J.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4586 - 4598
12345